PROCESS FOR LYOPHILISING A PRODUCT

Abstract

The present invention relates to a process for lyophilising a product (3), comprising the steps of providing a bulk product (3) loading system in the form of a bag (1), the bag (1) having an interior and an exterior defined by a flexible wall, the bag (1) further comprising a filling port (5) providing access to the interior of the bag (1), filling a product (3) having a first moisture content into the interior of the bag (1) via the filling port (5), and exposing the product (3) in the interior of the bag (1) to a lyophilisation cycle such that the moisture content of the product (3) is reduced from the first moisture content to a second, lower, moisture content.

Claims

1.-20. (canceled)

21. A method of lyophilizing a product comprising: a. filling a product into an interior of a bag, wherein the product comprises pharmaceutical-grade live anaerobic bacterial cells having a first moisture content; and b. exposing the product to a lyophilization cycle in a lyophilizer via a portion of the bag which is open, wherein the first moisture content of the product is reduced to a second moisture content, wherein the bag has an evaporative capacity of: (i) at least about 0.8×10.sup.−4 kg/s/m.sup.2 when measured at −10° C. and at 150 μbars; (ii) at least about 0.7×10.sup.−4 kg/s/m.sup.2 when measured at −10° C. and at 60 μbars; (iii) at least about 1.5×10.sup.−4 kg/s/m.sup.2 when measured at 0° C. and at 150 μbars; or (iv) at least about 1.0×10.sup.−4 kg/s/m.sup.2 when measured at 0° C. and at 60 μbars.

22. The method of claim 21, wherein the bag has an evaporative capacity of about 0.9×10.sup.−4 kg/s/m.sup.2 when measured at −10° C. and at 150 μbars.

23. The method of claim 21, wherein the bag has an evaporative capacity of about 0.8×10.sup.−4 kg/s/m.sup.2 when measured at −10° C. and at 60 μbars.

24. The method of claim 21, wherein the bag has an evaporative capacity of about 1.7×10.sup.−4 kg/s/m.sup.2 when measured at 0° C. and at 150 μbars.

25. The method of claim 21, wherein the bag has an evaporative capacity of about 1.2×10.sup.−4 kg/s/m.sup.2 when measured at 0° C. and at 60 μbars.

26. The method of claim 21, wherein the interior of the bag is defined by a flexible wall of the bag.

27. The method of claim 21, wherein the bag has two generally coplanar walls spaced apart by a side wall when filled.

28. The method of claim 27, wherein the two coplanar walls are substantially coplanar flexible walls.

29. The method of claim 27, wherein the side wall has a substantially constant height.

30. The method of claim 27, wherein the product is exposed to the lyophilization cycle by removing a portion of a wall of the bag.

31. The method of claim 30, wherein the removing of the wall of the bag is carried out after commencement of the lyophilization cycle.

32. The method of claim 21, further comprising removing the product from the bag.

33. The method of claim 32, further comprising preparing a dosage form of the product.

34. The method of claim 33, wherein the preparing comprises filling a capsule with the product.

35. A method of lyophilizing a product comprising: a. filling a product into an interior of a bag, wherein the product comprises pharmaceutical-grade live anaerobic bacterial cells having a first moisture content; and b. exposing the product to a lyophilization cycle in a lyophilizer via a portion of the bag which is open, wherein the first moisture content of the product is reduced to a second moisture content, wherein the bag has a global heat transfer coefficient (Kv) of: (i) at least about 0.007 when measured at −10° C. and at 60 μbars or 150 μbars; (ii) at least about 0.01 when measured at 0° C. and at 150 μbars; or (iii) at least about 0.008 when measured at 0° C. and at 60 μbars.

36. The method of claim 35, wherein the bag has a global heat transfer coefficient (Kv) of about 0.008 when measured at −10° C. and at 60 μbars or 150 μbars.

37. The method of claim 35, wherein the bag has a global heat transfer coefficient (Kv) of about 0.012 when measured at 0° C. and at 150 μbars.

38. The method of claim 35, wherein the bag has a global heat transfer coefficient (Kv) of about 0.01 when measured at 0° C. and at 60 μbars.

39. The method of claim 35, wherein the bag has two generally coplanar walls spaced apart by a side wall when filled.

40. The method of claim 39, wherein the product is exposed to the lyophilization cycle by removing a portion of a wall of the bag.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0088] By way of example, one or more embodiments of the present invention will now be described with reference to the accompanying drawings in which:

[0089] FIG. 1 is a schematic drawing of an apparatus for use in a process according to a first embodiment of the present invention, with a bag in a first filling orientation;

[0090] FIG. 2 is a schematic drawing of the apparatus of FIG. 1, with the bag in a second filling orientation;

[0091] FIG. 3 shows a plurality of bags which have been filled by a process according to the present invention, where the bags are stored in both a first vertical orientation and a second horizontal orientation;

[0092] FIG. 4A shows two perspective views and one end view of an unfilled bag for use in a process according to the present invention;

[0093] FIG. 4B shows a side and a front view of a bag that has been filled using a process according to the present invention;

[0094] FIG. 5 is a graph showing a comparison of the evaporative capacity determined at a temperature of −10° C. for processes according to the present invention and processes using conventional lyophilisation apparatus;

[0095] FIG. 6 is a graph showing a comparison of the evaporative capacity determined at a temperature of 0° C. for processes according to the present invention and processes using conventional lyophilisation apparatus;

[0096] FIG. 7 is a graph showing a comparison of the Global heat transfer coefficient (Kv) determined at a temperature of −10° C. for processes according to the present invention and processes using conventional lyophilisation apparatus; and

[0097] FIG. 8 is a graph showing a comparison of the Global heat transfer coefficient (Kv) determined at a temperature of 0° C. for processes according to the present invention and processes using conventional lyophilisation apparatus.

DETAILED DESCRIPTION OF THE DRAWINGS

Example 1—Bulk Loading System

[0098] FIG. 1 illustrates a process for lyophilising a product according to the present invention in which a bulk product loading system in the form of a bag 1 is provided. The bag 1 has an interior and an exterior defined by a flexible wall. The bag 1 comprises a filling port 5 which provides access to the interior of the bag 1, and through which the interior of the bag 1 is filled with a product 3 having a first moisture content. The product 3 is pumped from a storage hopper 9 using a filling pump 7. In conventional systems, to minimise the risk of contamination, product is only filled into the lyophilisation try shortly prior to lyophilisation. This synchronisation of the filling and lyophilisation steps requires a high level of user attention and planning. In contrast, in the process of the present invention, given that the bag 1 may be fitted with a closure, once filling is completed, the bag 1 can be closed and stored until a time at which lyophilisation is to occur.

[0099] As can be seen in FIG. 1, owing to the dimensions of the bag 1, the product 3 stored therein has uniform thickness. This is advantageous as it facilitates the uniform removal of moisture from the product 3 during lyophilisation. Additionally, as shown in FIG. 2, the bag can be filled at different orientations and its dimensions cause the product to be distributed evenly; in FIG. 1 the bag 1 is filled in a horizontal orientation, and in FIG. 2 the bag is filled in a vertical orientation.

[0100] As can be seen from FIG. 3, the bags 1 can be loaded onto lyophilisation shelves at different orientations (for example, vertical or horizontal) without an unacceptable loss in uniformity of product.

[0101] FIGS. 4A and 4B provide a range views of the unfilled (FIG. 4A) and filled (FIG. 4B) bags 1. As can be seen from these figures, the bag 1 is provided with two planar panels 2 spaced apart by a side wall 4. The height of the side wall 4 is constant, meaning that the interior of the bag 1 has a relatively fixed height, ensuring that the product 3 filled therein is of uniform depth.

[0102] As is apparent from this example, the bags 1 used in the process of the present invention can be used continuously in several stages of the formulation process, from receiving and storing the moist product during storage, during lyophilisation, and during post-lyophilisation storage. Conventionally used lyophilisation trays could not be used for prolonged storage of pharmaceutical grade products, either pre- or post-lyophilisation.

Example 2—Performance of Processes According to the Present Invention Versus Processes Using Conventional Lyophilisation Apparatus

[0103] Tests were conducted to evaluate the freeze drying performance of the process of the present invention as compared to processes using conventionally used apparatus. The bag of Example 1 was tested (both with its filling port opened (shown as “uncut”) and with part of its exterior cut away (shown as “cut”)) alongside a PETG plastic tray, a stainless steel tray (inox) and a Lyoguard tray. The containers were filled with water, frozen and freeze-dried for a defined period at two primary drying temperatures (−10° C. and 0° C.) and two chamber pressures (150 μbars and 60 μbars). The water quantity was measured, which enabled evaporative capacity and the global heat transfer coefficient, Kv, to be determined for each system. The results are shown in FIGS. 5 to 8.

[0104] As can be seen, the performance of the system of the invention was comparable to that of the Lyoguard tray. Advantageously, however, the bags employed in the present invention cost only a few euros to manufacture, whereas the Lyoguard trays retail at in excess of €100 per tray. Indeed, as can be seen from FIGS. 5 to 8, in some of the tests, the bag of the present invention out-performed the Lyoguard tray.

Example 3—Viability of Bacterial Strains Lyophilised Using the Process of the Present Invention

[0105] Three compositions comprising separate bacterial strains (Roseburia hominis (Strain A), Bifidobacterium breve (Strain B) and Enterococcus gallinarum (Strain C)) as well as sucrose/cysteine lyoprotectants were filled into separate bags as described in Example 1 and then the bags were sealed by closing the filling ports. The contents of the bags were then frozen and the bags loaded into a freeze dryer. As this happened, the end of the bag furthest from the filling port was removed, exposing the interior of the bag, and the cut bag was then subjected to lyophilisation cycles, according to the conditions shown below:

TABLE-US-00001 Strain A Values Temperature primary −25° C. to −10° C. desiccation (PD) Vacuum PD 150 μbars Temperature secondary +25° C. desiccation (SD) Vacuum SD 50 μbars

TABLE-US-00002 Strain B Values Temperature primary −30° C. to −10° C. desiccation (PD) Vacuum PD 50 μbars Temperature secondary +25° C. desiccation (SD) Vacuum SD 50 μbars

TABLE-US-00003 Strain C Values Temperature primary −20° C. to +10° C. desiccation (PD) Vacuum PD 150 μbars Temperature secondary +25° C. desiccation (SD) Vacuum SD 50 μbars

[0106] Bacterial cell counts were carried out before and after lyophilisation. The results are shown in the table below:

TABLE-US-00004 Strain Viability before freeze drying Viability after freeze drying Strain A 1.10.sup.10 CFU*/g dry matter  1.10.sup.10 CFU/g dry matter Strain B 3.10.sup.11 CFU/g dry matter 1.10.sup.11 CFU/g dry matter Strain C 4.10.sup.12 CFU/g dry matter 2.10.sup.12 CFU/g dry matter *Colony Forming Units
As is apparent, the bags of Example 1 advantageously permitted three different bacterial strains to be lyophilised without any significant or unacceptable loss in viability.

[0107] It will be appreciated that the embodiments shown in the figures and described above are by way of example only, and that alterations or modifications may be made within the scope of the invention as defined in the following claims.